We are live on ! Find out more
FLACU

Frazier Lifesciences Acquisition Corp Unit

Delisted

FLACU was delisted on the 22nd of November, 2022.

0 hedge funds and large institutions have $0 invested in Frazier Lifesciences Acquisition Corp Unit in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 14 → 0 (-14)

100% less capital inflows, than outflows

Capital inflows: $0 | Capital outflows: $31M

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 14

Holders
–
Holders Change
-14
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

FLACU Hedge Fund Activity: Q4 2022 in Review

0 of the 6,245 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corp Unit (FLACU) for Q4 2022, worth a combined $0 — down 100% from $31M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of FLACU and 0 opened new positions — a net loss of 14 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Frazier Life Sciences Management, exiting entirely with an estimated $15.2M sold.

  • 0 institutional investors held Frazier Lifesciences Acquisition Corp Unit (FLACU) as of Q4 2022, down from 14 in Q3 2022.
  • Funds reported $0 of Frazier Lifesciences Acquisition Corp Unit stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Frazier Lifesciences Acquisition Corp Unit positions in Q4 2022 and 14 closed out, a net change of -14 holders.
  • The largest Frazier Lifesciences Acquisition Corp Unit seller in Q4 2022 was Frazier Life Sciences Management, an estimated $15.2M sold.

Based on aggregated 13F filings for Q4 2022.